Title 42, The Public Health and WelfareRelease 119-110

§300hh–31 Epidemiology-laboratory Capacity Grants

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER XXVI — NATIONAL ALL-HAZARDS PREPAREDNESS FOR PUBLIC HEALTH EMERGENCIES › Part C — Strengthening Public Health Surveillance Systems › § 300hh–31

Last updated Sep 22, 2026|Official source

Summary

If money is available, the HHS Secretary, through the CDC director, must set up an Epidemiology and Laboratory Capacity Grant Program to give grants to state, local, and tribal health departments that meet CDC criteria. Academic centers that help those health departments can also get money if the CDC allows. Grants must help public health agencies find and track infectious and other important diseases, improve labs and electronic test reporting, upgrade information systems and data exchanges under national guidance, and create prevention and control plans. Congress authorized $190,000,000 for each fiscal year 2019 through 2023. At least $95,000,000 each year must go to strengthening disease tracking and prevention efforts, at least $60,000,000 to information systems, and at least $32,000,000 to labs and electronic reporting.

Full Legal Text

Title 42, §300hh–31

The Public Health and Welfare, Source: USLM XML via OLRC

(a)In general
Subject to the availability of appropriations, the Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish an Epidemiology and Laboratory Capacity Grant Program to award grants to State health departments as well as local health departments and tribal jurisdictions that meet such criteria as the Director determines appropriate. Academic centers that assist State and eligible local and tribal health departments may also be eligible for funding under this section as the Director determines appropriate. Grants shall be awarded under this section to assist public health agencies in improving surveillance for, and response to, infectious diseases and other conditions of public health importance by—
(1)strengthening epidemiologic capacity to identify and monitor the occurrence of infectious diseases, including mosquito and other vector-borne diseases, and other conditions of public health importance;
(2)enhancing laboratory practice as well as systems to report test orders and results electronically;
(3)improving information systems including developing and maintaining an information exchange using national guidelines and complying with capacities and functions determined by an advisory council established and appointed by the Director; and
(4)developing and implementing prevention and control strategies.
(b)Authorization of appropriations
There are authorized to be appropriated to carry out this section $190,000,000 for each of fiscal years 2019 through 2023, of which—
(1)not less than $95,000,000 shall be made available each such fiscal year for activities under paragraphs (1) and (4) of subsection (a);
(2)not less than $60,000,000 shall be made available each such fiscal year for activities under subsection (a)(3); and
(3)not less than $32,000,000 shall be made available each such fiscal year for activities under subsection (a)(2).

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Amendments

2019—Subsec. (a)(1). Pub. L. 116–22, § 607(b)(1), inserted “, including mosquito and other vector-borne diseases,” after “infectious diseases”. Subsec. (b). Pub. L. 116–22, § 607(b)(2), substituted “2019 through 2023” for “2010 through 2013” in introductory provisions.

Reference

Citations & Metadata

Citation

42 U.S.C. § 300hh–31

Title 42, The Public Health and Welfare

Last Updated

Sep 22, 2026

Release point: 119-110